| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Revenue | $24.94B | -3.5% |
| Cost of Revenue | $16.63B | -1.5% |
| Gross Profit | $8.31B | -7.3% |
| R&D Expense | $167.0M | +11.3% |
| SG&A Expense | $12.98B | +78.1% |
| Operating Income | -$4.67B | -377.4% |
| Interest Expense | $947.0M | +3.8% |
| Pre-tax Income | -$5.45B | -736.1% |
| Income Tax | $403.0M |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.62B | +96.0% |
| Accounts Receivable | $2.25B | +5.0% |
| Inventory | $3.17B | -6.2% |
| Current Assets | $10.13B | +32.3% |
| Total Assets | $81.79B | -7.4% |
| Current Liabilities | $8.78B | +21.0% |
| Long-term Debt | $19.31B | +0.5% |
| Line Item | 2025-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.46B | +6.6% |
| Capital Expenditures | $801.0M | -21.8% |
| Investing Cash Flow | -$1.83B | -79.2% |
| Financing Cash Flow | -$1.25B | +58.4% |
| Free Cash Flow | $3.66B | +15.9% |
| +121.3% |
| Net Income | -$5.85B | -313.0% |
| EPS (Basic) | -$4.93 | -317.2% |
| EPS (Diluted) | -$4.93 | -318.1% |
| Total Liabilities |
| $40.00B |
| +2.7% |
| Stockholders' Equity | $41.66B | -15.3% |